Newsweek spotlights three digital health gems in Altaroc portfolio

The American magazine Newsweek has published its global ranking of the best digital health companies, highlighting the most disruptive technological infrastructures in the medical sector. Among the winners are three key investments from VintageAltaroc. This recognition comes amid unprecedented growth in the global digital health market. Estimated at $427.24 billion in 2025, this sector is projected to reach $491.62 billion as early as 2026, driven by a compound annual growth rate of 21.60%, according to projections by Fortune Business Insights. Fundraising activity reflects this momentum, with investment in digital health startups reaching $14.2 billion over the past year, and more than half of that capital directed toward solutions incorporating artificial intelligence.

Performance validated by clinical research and market adoption

The recognition of these three companies is based not only on theoretical innovation, but also on rigorous clinical impact data and major fundraising rounds led by leading institutional investors.

Heartbeat Health: Drastic Reduction in Cardiac Rehospitalizations

Heartbeat Health is revolutionizing cardiology with a digital platform that combines telemedicine and artificial intelligence. Specializing in the early detection and proactive management of cardiovascular diseases, the company enables patients to access specialized care quickly and efficiently. With Heartbeat Health, prevention and personalized care are at your fingertips, improving health outcomes and reducing cardiac complications.

On the financial front, the company has solidified its national expansion by raising $20 million in Series B funding led by Echo Health Ventures, alongside DaVita Venture Group and Optum Ventures, bringing its total capital raised to more than $30 million.

The impact of his solution was the subject of a randomized clinical trial published in the journal BMJ Innovations. The results show that its 100-day post-hospitalization virtual program reduces readmissions for cardiac causes by 53% and rehospitalizations for all causes by 44% within 90 days of the patient’s discharge. The study data also highlight concrete physiological benefits, with an average decrease of 11 mmHg in systolic blood pressure among the patients monitored.

Biofourmis: Predictive Telemedicine Rises to Unicorn Status

Biofourmis is redefining healthcare with solutions based on artificial intelligence and wearable technologies. Specializing in predictive medicine and chronic disease management, Biofourmis’s platform analyzes data in real time to anticipate changes in health status and adjust treatments accordingly. This approach enables patients and healthcare providers to respond quickly and improve treatment outcomes.

Operating in the highly strategic home care (Care at Home) segment, Biofourmis achieved unicorn status following the completion of a $300 million Series D funding round led by General Atlantic, with strategic participation from healthcare giant CVS Health. This round brought the company’s total funding to $445 million.

Biofourmis’ operational efficiency translates into key clinical performance indicators for its partner hospital systems: a 48% decrease in 30-day readmission rates, a 64% decrease in emergency department visits, and an average reduction of 3.7 days in the length of conventional hospital stays, resulting in an overall savings of $70.6 million in hospital bed allocation costs.

Element 5: Smart Automation vs. Administrative Burden

Element5 automates administrative processes for healthcare providers using artificial intelligence, freeing up time for medical teams and reducing human error. By streamlining repetitive tasks such as billing and authorizations, Element5 allows healthcare professionals to focus on what matters most: providing quality care to patients.

The company specifically operates as a provider of workflow automation (Automation-as-a-Service) in the post-acute care market, a sector estimated to be worth $400 billion in the United States that includes nursing facilities, hospice care facilities, and senior living communities.

To support its market expansion, Element5 has closed a $30 million Series B funding round led by the international investment firm Insight Partners, bringing its total funding to $48.5 million. By deploying AI-powered robotic process automation (RPA) technology, Element5 enables institutions to eliminate time-consuming manual tasks related to admissions, revenue cycle management, and pre-authorization requests from insurers.

Editorial recognition rooted in the history of major rankings

Newsweek is an American news magazine founded in 1933. It is renowned for its in-depth coverage of national and international topics, with political, economic, cultural and scientific analyses. Over the decades, it has established itself as one of the world's leading news magazines, with editions in several languages and readers in many countries. In addition to its editorial content, the magazine also publishes influential rankings, such as that of the best companies in growth sectors, including digital health.

-----

Advertising communication. Please refer to the FIA prospectus and key investor information documents before making any final investment decision. Private equity involves a risk of capital loss and a liquidity risk. Past performance is no guarantee of future results.

‍